Modi Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Cytospire Therapeutics secures £61m Series A led by 4BIO Capital for cancer therapies that activate the body’s immune cells
Cytospire Therapeutics develops multispecific immune cell engager antibodies designed to enhance and direct the activity of the body’s immune system. Its platform targets gamma delta T cells to generate anti tumour immune responses for patients with cancer and other diseases.
Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
Brainomix develops medical imaging software that helps clinicians assess stroke and lung fibrosis using automated image analysis. Its platforms support diagnosis and treatment decisions by analysing scans and providing clinical insights at the point of care.
Ignota Labs raises £5.5m seed led by Montage Ventures and AIX Ventures to turn around failed drugs
Ignota Labs applies AI-driven drug discovery to rescue and redevelop failed drug candidates, identifying and resolving safety issues so promising therapies can be revived and progressed back into clinical development.
- 2(12 months)
- modivc.com
- Update Information
More venture news
- 26 Aug 2026
Certain EnergyCertain Energy raises a £10m Series A led by British Business Bank for long-duration battery storage on the clean energy grid
Series AEnergy - 12 Aug 2026
MindgardMindgard secures £22m Series A led by Album VC to test and defend AI systems against adversarial attack
Series ACybersecurity - 12 Aug 2026
CytixCytix raises a £5m Series A round led by Northern Gritstone to manage the security risk of AI-driven software change
Series ACybersecurity
